Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteiTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
A 2020 analysis estimated that exposure to four chemical classes accounted for a large population-level burden of lost IQ points in the United States from 2001 to 2016. Chemistry World summarized the total as 270 million IQ points. That figure is a modeled estimate, not a count of children whose IQ was individually measured; the primary paper also reports a separate, unadjusted sum of 326 million IQ points.
Which chemicals were included?
The study examined polybrominated diphenyl ethers (PBDEs), organophosphates, methylmercury, and lead. It estimated burden associated with prenatal exposure to PBDEs, organophosphates, and methylmercury, and with early-life exposure to lead. The analysis covered U.S. data from 2001 through 2016.
PBDEs were the largest estimated contributor in the paper: 162 million IQ points and 738,000 intellectual-disability cases across the study period. Methylmercury accounted for less than 1% of the paper’s unadjusted summed IQ-point loss. The available results do not establish comparable exact totals for lead and organophosphates, so assigning them specific figures would overstate what is reported here.
What does the 270 million figure mean?
It is Chemistry World’s 2020 summary of the study’s estimated population burden from 2001 to 2016—not a direct measurement of IQ changes in named individuals, and not a monetary cost. The researchers combined National Health and Nutrition Examination Survey (NHANES) data with previously established relationships between exposures and health outcomes to estimate attributable burden, including IQ-point losses and intellectual-disability cases.
#1 Best Overall
The numbers require a distinction: Chemistry World reported 270 million IQ points, while the primary paper’s indexed text reports an unadjusted sum of 326 million across the four chemicals. These are not interchangeable totals. The available account does not establish the exact adjustment or calculation that connects them, so the 270 million figure should be attributed to the news coverage rather than presented as the paper’s unqualified summed result.
How did the estimated burden change?
Chemistry World reported that the estimated total fell from 27 million IQ points in 2001–2002 to 9 million in 2015–2016. The paper’s abstract says estimated IQ loss associated with PBDEs, methylmercury, and lead decreased or remained stagnant over 2001–2016. Organophosphate exposure measurements were available only through 2008; within that measured period, estimates of organophosphate-attributable IQ loss increased. That cutoff means the study cannot provide the same exposure-based comparison for organophosphates through 2016.
The researchers also cautioned that reductions in some exposures can coincide with substitution by other chemicals that may pose risks. The reported trends therefore describe the chemicals and measurements included in this analysis, not a complete accounting of every possible neurodevelopmental exposure.
Free tools Windows power users keep installed
One-click scans. No signup required.
What the study can—and cannot—show
Gaylord and colleagues’ population-based disease-burden and cost analysis, published in Molecular and Cellular Endocrinology in 2020, estimates outcomes attributable to modeled exposure relationships. It is not a clinical trial, nor a census of observed individual IQ losses. Aggregating estimated IQ-point losses is a way to express population burden; it does not mean each exposed child lost the same number of points.
The analysis is historical, covering 2001–2016, and its findings depend on the exposure data and established exposure-disease relationships used. It should not be read as a current estimate of U.S. exposure or as a comparison of present-day chemical risks.
Quick Recap
Best Value
Sources
- Gaylord A, Osborne G, Ghassabian A, Malits J, Attina T, Trasande L, “Trends in Neurodevelopmental Disability Burden due to Early Life Chemical Exposure in the USA from 2001 to 2016: A Population-Based Disease Burden and Cost Analysis,” Molecular and Cellular Endocrinology 502 (2020), 110666. Primary article; PubMed record.
- Rebecca Trager, “Four chemical classes cost US public 270 million IQ points over 15 years,” Chemistry World, 28 January 2020. Article.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
